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Abstract
Background: Bacterial non-necrotizing erysipelas and cellulitis are often recurring, diffusely spreading infections of the skin
and subcutaneous tissues caused most commonly by streptococci. Host genetic factors influence infection susceptibility but
no extensive studies on the genetic determinants of human erysipelas exist.
Methods:We performed genome-wide linkage with the 10,000 variant Human Mapping Array (HMA10K) array on 52 Finnish
families with multiple erysipelas cases followed by microsatellite fine mapping of suggestive linkage peaks. A scan with the
HMA250K array was subsequently performed with a subset of cases and controls.
Results: Significant linkage was found at 9q34 (nonparametric multipoint linkage score (NPLall) 3.84, p = 0.026), which is
syntenic to a quantitative trait locus for susceptibility to group A streptococci infections on chromosome 2 in mouse.
Sequencing of candidate genes in the 9q34 region did not conclusively associate any to erysipelas/cellulitis susceptibility.
Suggestive linkage (NPLall.3.0) was found at three loci: 3q22-24, 21q22, and 22q13. A subsequent denser genome scan with
the HMA250K array supported the 3q22 locus, in which several SNPs in the promoter of AGTR1 (Angiotensin II receptor type
I) suggestively associated with erysipelas/cellulitis susceptibility.
Conclusions: Specific host genetic factors may cause erysipelas/cellulitis susceptibility in humans.
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Introduction
Bacterial non-necrotizing erysipelas and cellulitis are often
recurring, diffuse, and spreading infections of the skin and
subcutaneous tissues, which manifest with local erythema, pain,
and warmth usually accompanied by fever, leukocytosis, lym-
phangitis, and lymphadenitis [1]. Both Group A (Streptococcus
pyogenes) and G (typically Streptococcus dysgalactiae subsp. equisimilis) b-
hemolytic streptococci are the predominant causative agents of
cellulitis/erysipelas but infections may also be caused by group B
and C streptococci and Staphylococcus aureus [1,2]. Risk factors for
erysipelas/cellulitis include impaired lymphatic drainage, venous
insufficiency, skin eruptions and trauma, and obesity [3–5].
Erysipelas/cellulitis causes significant morbidity and recurrence
is common especially with tibial involvement, history of malig-
nancy, dermatitis or prior surgery of the affected limb [3–6]. The
course of a clinical infection is the outcome of the host genome, the
pathogens’ virulence, and the environment. Interindividual
variation between hosts can cause infections to range from
asymptomatic to fatal infection, e.g. the same group A strepto-
coccal (GAS) strain can be carried asymptomatically, cause
uncomplicated pharyngitis or potentially fatal bacteremia such as
streptococcal toxic shock syndrome or necrotizing fasciitis [7].
Twin, sibling, and adoption studies have recognized genetic factors
as important determinants of susceptibility to infectious diseases,
but recurrent infections and clustering in families still involve
unknown genetic and immunological factors [8].
Mendelian and polygenic host genetic factors are known to
influence susceptibility to infection by bacteria, parasites, and
viruses including Mycobacterium leprae, Mycobacterium tuberculosis,
Streptococcus pneumoniae, Neisseria meningitidis, Schistosoma mansoni,
Leishmania donovani, Epstein-Barr virus, and human papilloma virus
[9,10]. Conversely, resistance is known for Plasmodium vivax,
human immunodeficiency virus-1, meningococcal disease, and
norovirus [9,10]. Genome-wide scans have identified susceptibility
loci for leishmaniasis (22q12, 2q23-31), leprosy (10p13, 6q25), and
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tuberculosis (15q, Xq) [11–14]. Host genetics is a significant factor
in determining susceptibility to severe GAS sepsis in mouse and
severe invasive GAS infection in humans [7,15]. Mouse suscep-
tibility loci for GAS infection have been mapped to chromosome
17, including the mouse MHC region (syntenic to human 6p21);
chromosome 7, which is also linked with susceptibility to
Streptococcus pneumoniae infection in mice (syntenic to human
19q13.1-13.3); and chromosome 2, including genes of the
interleukin 1 alpha, and prostaglandin E synthetase pathways
(syntenic to human 2q14 and 9q33-34) [16–18]. Specific Human
Leukocyte Antigen class II (HLAII) haplotypes protect from severe
systemic disease caused by GAS whereas other haplotypes increase
the risk of severe disease [19,20]. HLAII molecules are receptors
for microbial superantigens and their allelic variations can regulate
cytokine responses. The intensity of an individual’s inflammatory
cytokine response correlates directly with the severity of infection:
a higher cytokine response leads more often to severe systemic
disease than lower cytokine levels [19]. The HLA/MHC region in
humans has also been associated with the susceptibility to many
other infectious diseases, e.g., HIV/AIDS, hepatitis, leprosy,
tuberculosis, malaria, leishmaniasis, and schistosomiasis [21].
We have used erysipelas/cellulitis (hereafter referred to as
erysipelas) as a marker infection to identify families with two or
more family members suffering from erysipelas and suggesting
a possibly increased susceptibility to streptococcal infections. To
identify putative susceptibility loci we performed a whole-genome
genetic linkage scan and identified suggestive loci on chromosomes
9q34, 3q22-24, 21q22, and 22q13.
Materials and Methods
Ethics Statement
This study was approved by the Ethical Review Board of
Pirkanmaa Hospital District, Tampere, Finland. Written informed
consent was obtained from all study participants. All clinical
investigations have been conducted according to the principles
expressed in the Declaration of Helsinki.
Patients and Families
We recruited individuals with recurrent erysipelas infections for
which preventive monthly intramuscular benzathine penicillin
injections are reimbursed in Finland. We contacted all 960
individuals reimbursed for benzathine penicillin through the
National Health Insurance Institution in the year 2000. Of these,
50% (483) gave consent to participate and 25% had a first-degree
relative with a history of erysipelas. We then collected blood
samples from 204 recurrent erysipelas patients and 124 relatives
from 52 pedigrees with two or more family members suffering
from erysipelas. The diagnosis of erysipelas was verified from
hospital records for all patients except for six who self-reported to
have had erysipelas but no hospital records were available for
verification.
An acute erysipelas cohort of 90 patients with acute erysipelas
and 90 population controls matched for age and sex was also
recruited. An infectious disease specialist recruited the patients
from Tampere University Hospital and Hatanpa¨a¨ City Hospital,
Tampere, Finland when they were hospitalized for erysipelas. The
cohort is described in detail elsewhere [5].
Genomic Screen for Non-parametric Linkage
Samples from twenty affected individuals from six most
representative families (Figure 1) were genotyped using Affymetrix
GeneChip Human Mapping 10K Array v 1.0 (Affymetrix, Santa
Clara, CA, USA). A total of 11,145 autosomal single nucleotide
polymorphisms (SNPs) were used for analysis, with 82–962 SNPs
per chromosome. The median physical distance between SNPs
was 210 kb (genetic distance ranging from 0.24–1.12 cM), and the
average heterozygosity was 0.37. Physical coordinates were
mapped against the GRCh37.2 human genome assembly and
the deCODE genetic map was used for genetic locations [22].
MERLIN (Multipoint Engine for Rapid Likelihood Inference)
software [23] was used for multipoint nonparametric linkage
(NPL) analysis. Allele frequencies were estimated from data on 20
affected individuals, and SNPs with unlikely genotypes were
removed prior to analysis. The genome-wide significance of NPLall
scores was estimated by simulating data 100 times with MERLIN
and extracting the highest NPLall score from each simulation. The
minimum NPLall score for suggestive linkage was 2.1 (occurring
once at random in a genome scan) and the threshold for significant
linkage 4.77 (occurring with a 5% probability in a genome scan).
Non-parametric linkage analysis was repeated using Caucasian
allele frequency estimates obtained from Affymetrix.
Verification of Linkage Peaks
The NPL results were verified with 31 microsatellites surround-
ing the suggested linkage peaks at 3q22-24, 9q34, 21q22, and
22q13 at approximately 2 cM (0.85–2.2 Mb) intervals (Table 1).
We genotyped 91 individuals (54 affected, 31 non-affected, and six
who were defined unconfirmed as their erysipelas diagnosis could
not be verified) from 19 families using PCR followed by capillary
electrophoresis. Further fine mapping of the 9q34 linkage peak
(131527468 - 135831155 bp) was performed with 22 microsatel-
lites from 130457260 to 136035489 bp (Table 2). PCR assays
were performed in 5 ml volumes containing 20 ng of DNA with
standard reagent concentrations and temperature profiles. Fluor-
escently labeled PCR products were run on an ABI 377 sequencer.
Allele calling was performed using Genotyper 2.0 (Applied
Biosystems).
MERLIN was used for multipoint NPL analysis as described
above. Allele frequencies were estimated from all individuals, non-
affected individuals were assigned affection status unknown, and
Mendelian inconsistent genotypes were removed prior to analysis.
Linkage analysis was done using two configurations: 0; the
unconfirmed affected individuals were analyzed as unknown,
and 2; they were analyzed as affected. The genome-wide
significance of NPLall scores for configuration 0 was estimated
by simulating data 1000 times with MERLIN and extracting the
highest NPLall score from each simulation. Minimum NPLall score
for significant linkage was 2.49, p = 0.05. For fine mapping of
9q34, linkage analysis was done using four configurations: 0;
unconfirmed affected individuals were analyzed as unknown, and
2; they were analyzed as affected. In configurations 0_186 and
2_186, analysis was identical except that allele 186 was called for
marker D9S65.
Follow-up Genomic Screening with Higher-density Array
We selected 15 affected patients and 15 unaffected controls
for additional genomic screening with the Affymetrix GeneChip
Human Mapping 250KSty Array to search for possible allele or
haplotype associations assuming a strong genetic effect. Twelve
patients were from the families 1, 2, 4, 5, 8, 9, 12, 14, 22, 32,
37, and 38, and their genetically independent family members
served as controls. Three patients and three controls were from
the acute cohort. Genotypes were called with BRLMM using
Affymetrix default parameters. Analysis focused on the defined
linkage peaks: 3q22-24 (D3S1306-D3S1299), 9q34 (D9S290-
D9S1863), 21q22 (D21S1898-D21S1920), and 22q31
(D22S1159-D22S1141) (Table 1). To evaluate potential differ-
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ences of haplotype frequencies between cases and controls,
shared heterozygosity among cases was checked, allelic associ-
ation was analyzed by using Haploview, and haplotype
association was analyzed by both Haploview and Haplotype
Pattern Mining [24,25].
Candidate Gene Analyses
Altogether five candidate genes in the 9q34 linkage peak were
chosen based on their biological relevance in immunity or
infections (Table 2). After PCR with flanking intronic primers,
all exons were sequenced in index individuals from the six families
(11, 12, 13, 28, 40, and 46) showing most significant linkage (Table
S1). Similarly, exons and exon-intron boundaries of AGTR1
(Angiotensin II receptor, type 1) were sequenced in six probands
from the families (7, 13, 37, 40, 43, and 46) showing linkage to the
3q22 area. All PCR reactions were performed in 5 ml volumes
containing 20 ng of DNA, with standard reagent concentrations
and temperature profiles. Sequencing was performed using dye-
terminator chemistry and automated sequencers (ABI, Columbia,
Maryland, United States). Primer sequences are available on
request.
Results
Initial Non-parametric Genome-wide Linkage Results
We found seven suggestive linkage peaks on chromosomes
9q34, 3q22-24, 21q22, 22q13, 3p24, 10q25, and 11q24, in
descending order of genomic significance, on the Affymetrix
HMA10K Array (Table 3, Figure 2). The strongest linkage was on
chromosome 9q34 (rs578802- rs708616), with an NPLall score of
3.84 and a suggestive genome-wide p-value of 0.24. Results were
identical when the analysis was repeated with Caucasian allele
frequency estimates from Affymetrix, except that the chromosome
3 peak marker moved from 3p24 (rs1994987) to 3p22 (rs2167176)
with an NPLall score of 2.64 and a genome-wide P-value 0.94.
Generally, different families contributed strongest to the most
significant peaks: 9q34 (Families 12 NPLall 3.2 and 13 NPLall 4.8);
3q22-q24 (Families 13 NPLall.5 and 37 NPLall 2.0); 21q22
(Families 12 NPLall 3.7 and 21 NPLall 2.5); and 22q13 (Families 12
NPLall 2.0 and 31 NPLall 1.7).
Verification of Linkage Peaks
Genotyping 91 affected and non-affected individuals from 19
families with 31 microsatellite markers surrounding the four
most suggestive linkage peaks on 3q22-24, 9q34, 21q22, and
22q13 revealed one significant linkage peak for 9q34 with the
highest NPLall of 2.77 and p = 0.026 for D9S159 (minimum
NPLall score for significant linkage was 2.49) (Table 1). Only
suggestive linkage was seen for 3q22-24, 21q22, and 22q13
(Table 1). The highest NPLall score was at 9q34 in both
configurations. Families 12 and 13 contributed again strongest
to the linkage peak on chromosome 9q34, with the highest
NPLall scores of 3.64 at D9S179 and 5.02 at D9S313,
respectively, and four other families showed suggestive linkage
(NPLall scores of 1.34–1.41) (Table S1).
Figure 1. The six most representative families used for initial linkage analysis. Arrows indicate probands and asterisks other family
members studied.
doi:10.1371/journal.pone.0056225.g001
Genetic Susceptibility to Erysipelas
PLOS ONE | www.plosone.org 3 February 2013 | Volume 8 | Issue 2 | e56225
T
a
b
le
1
.
N
o
n
-p
ar
am
e
tr
ic
lin
ka
g
e
re
su
lt
s
fr
o
m
u
si
n
g
ad
d
it
io
n
al
m
ic
ro
sa
te
lli
te
m
ar
ke
rs
su
rr
o
u
n
d
in
g
th
e
su
g
g
e
st
e
d
lin
ka
g
e
p
e
ak
s.
C
h
ro
m
o
so
m
a
l
lo
cu
s
M
a
rk
e
r
G
e
n
e
ti
c
lo
cu
s
(c
M
)
P
h
y
si
ca
l
lo
cu
s
(b
p
)
C
o
n
fi
g
u
ra
ti
o
n
0
C
o
n
fi
g
u
ra
ti
o
n
0
C
o
n
fi
g
u
ra
ti
o
n
2
M
b
b
e
tw
e
e
n
m
a
rk
e
rs
(t
o
ta
l
a
re
a
o
n
C
h
r)
N
P
L
a
ll
G
e
n
o
m
e
-w
id
e
p
-v
a
lu
e
N
P
L
a
ll
3
q
2
2
-2
4
D
3
S1
2
3
8
1
4
2
.6
0
1
3
3
9
1
5
4
0
4
0
.9
8
0
.6
9
2
1
.1
0
D
3
S1
5
7
6
1
4
4
.4
6
1
3
7
4
2
0
0
0
9
1
.0
4
0
.6
6
0
1
.1
6
3
.5
0
D
3
S1
3
0
9
1
4
6
.6
3
1
4
0
7
2
6
5
4
6
0
.9
6
0
.7
0
3
1
.0
5
3
.3
1
D
3
S3
6
9
4
1
4
8
.8
2
1
4
2
1
9
0
8
7
8
0
.9
5
0
.7
0
8
1
.0
4
1
.4
6
D
3
S1
5
6
9
1
5
0
.5
8
1
4
3
3
7
1
5
9
4
0
.8
5
0
.7
6
2
0
.9
4
1
.1
8
D
3
S1
5
9
3
1
5
2
.3
1
1
4
5
3
2
8
0
2
3
0
.8
6
0
.7
6
1
0
.9
6
1
.9
6
D
3
S1
3
0
6
1
5
4
.1
8
1
4
7
8
0
1
0
3
8
1
.0
6
0
.6
5
1
1
.0
4
2
.4
7
D
3
S1
5
5
5
1
5
6
.5
9
1
4
8
8
0
7
2
0
1
1
.1
1
0
.6
2
9
0
.9
4
1
.0
1
D
3
S1
2
9
9
1
5
8
.5
6
1
5
0
1
8
3
8
6
0
1
.0
2
0
.6
6
9
0
.7
2
1
.3
8
D
3
S1
2
7
9
1
6
0
.1
9
1
5
1
0
2
5
2
6
0
0
.9
1
0
.7
3
2
0
.6
1
0
.8
4
D
3
S3
5
3
1
1
6
2
.7
9
1
5
4
2
1
3
3
6
6
0
.7
5
0
.8
0
3
0
.4
6
3
.1
9
D
3
S1
6
0
7
1
6
4
.6
1
1
5
6
9
6
4
1
2
5
0
.4
3
0
.9
2
1
0
.1
4
2
.7
5
D
3
S3
5
7
9
1
6
6
.4
5
1
6
0
5
8
0
2
7
7
0
.2
9
0
.9
5
9
0
.0
0
3
.6
2
(2
6
.6
6
)
9
q
3
4
D
9
S2
9
0
1
3
6
.4
0
1
3
1
5
2
7
4
6
8
2
.3
1
0
.0
7
4
2
.2
6
D
9
S
1
5
9
1
3
8
.1
3
1
3
2
3
6
9
6
9
4
2
.7
7
0
.0
2
6
2
.7
1
0
.8
4
D
9
S1
8
6
3
1
4
0
.3
5
1
3
3
4
9
9
8
4
5
2
.6
7
0
.0
3
4
2
.6
2
1
.0
8
D
9
S3
1
3
1
4
1
.0
4
1
3
3
8
8
7
4
1
4
2
.6
6
0
.0
3
5
2
.6
0
0
.3
9
D
9
S1
7
9
1
4
3
.1
9
1
3
5
0
9
1
6
2
8
2
.4
2
0
.0
6
3
2
.3
6
1
.2
0
D
9
S1
1
9
9
1
4
4
.5
1
1
3
5
8
3
1
1
5
5
2
.1
8
0
.1
0
4
2
.1
4
0
.7
4
(4
.2
5
)
2
1
q
2
2
D
2
1
S2
6
2
3
5
.6
8
3
3
8
1
6
3
0
6
1
.2
0
0
.5
6
0
1
.3
4
D
2
1
S1
8
9
8
3
7
.6
8
3
4
6
0
9
2
3
1
1
.3
2
0
.4
9
1
1
.4
7
0
.7
9
D
2
1
S1
4
4
5
3
8
.4
8
3
5
3
7
5
6
6
2
1
.3
3
0
.4
8
2
1
.4
8
0
.7
7
D
2
1
S1
9
2
0
3
8
.8
2
3
5
6
9
7
1
9
2
1
.3
1
0
.4
9
7
1
.4
6
0
.3
2
D
2
1
S1
8
9
5
3
9
.5
1
3
6
3
5
1
0
5
9
0
.9
2
0
.7
2
3
1
.0
1
0
.6
5
(2
.5
3
)
2
2
q
1
3
D
2
2
S1
1
7
1
5
3
.4
5
4
4
4
1
7
5
8
4
0
.4
4
0
.9
1
4
0
.4
9
D
2
2
S1
1
5
9
5
4
.6
2
4
4
7
5
0
6
1
5
0
.3
9
0
.9
3
3
0
.4
8
0
.3
3
D
2
2
S2
7
4
5
6
.4
7
4
5
2
6
9
1
5
2
0
.5
1
0
.8
8
9
0
.6
6
0
.5
2
D
2
2
S1
1
4
1
5
8
.5
9
4
5
7
1
8
9
0
0
0
.3
7
0
.9
3
8
0
.5
2
0
.4
5
D
2
2
S1
1
5
3
6
1
.8
2
4
6
4
0
4
5
1
1
0
.8
4
0
.7
6
6
0
.9
8
0
.6
9
D
2
2
S1
1
6
1
6
7
.4
3
4
7
5
9
6
3
3
1
0
.2
9
0
.9
5
9
0
.3
8
1
.1
9
D
2
2
S1
1
7
0
7
0
.9
8
4
8
3
5
0
7
3
6
0
.2
2
0
.9
6
7
0
.2
9
0
.7
5
(3
.9
3
)
T
h
e
m
o
st
si
g
n
if
ic
an
t
lo
cu
s
is
h
ig
h
lig
h
te
d
in
b
o
ld
.
P
h
ys
ic
al
co
o
rd
in
at
e
s
w
e
re
m
ap
p
e
d
ag
ai
n
st
th
e
G
R
C
h
3
7
.2
h
u
m
an
g
e
n
o
m
e
as
se
m
b
ly
.
T
h
e
d
e
C
O
D
E
g
e
n
e
ti
c
m
ap
w
as
u
se
d
fo
r
g
e
n
e
ti
c
lo
ca
ti
o
n
s
[2
2
]
an
d
fo
r
m
ar
ke
rs
ab
se
n
t
o
n
th
e
d
e
C
O
D
E
m
ap
,
g
e
n
e
ti
c
co
o
rd
in
at
e
s
w
e
re
e
st
im
at
e
d
w
it
h
lin
e
ar
in
te
rp
o
la
ti
o
n
u
si
n
g
th
e
m
ar
ke
rs
’
p
h
ys
ic
al
co
o
rd
in
at
e
s.
cM
=
ce
n
ti
M
o
rg
an
.
N
P
L a
ll
=
n
o
n
-p
ar
am
e
tr
ic
lin
ka
g
e
sc
o
re
w
h
e
n
te
st
in
g
fo
r
al
le
le
sh
ar
in
g
am
o
n
g
af
fe
ct
e
d
in
d
iv
id
u
al
s.
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
5
6
2
2
5
.t
0
0
1
Genetic Susceptibility to Erysipelas
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e56225
Chromosome 9q34 Microsatellite Fine Mapping by
Microsatellites
The chromosome 9q34 region was further fine mapped with 22
microsatellite markers in the same 91 individuals (Table 2).
Highest linkage (NPLall 2.9) was observed at D9S65
(132190620 bp) if allele 186 was called, otherwise it shifted to
marker D9S64 (134380110 bp) (NPLall 2.7). NPL plots for the four
configurations were essentially unchanged (Table 2, Figure S1).
Altogether, 59 annotated protein-coding genes are located
within the chromosome 9q34 linkage peak (D9S290 to D9S1199)
(Table 2). The five functionally most interesting genes were
sequenced in the index individuals from the six families showing
most significant linkage to 9q34 (Table S1, Table 2). PRRX2
(Paired related homeobox 2) is expressed in proliferating fetal
fibroblasts and the developing dermal layer, with lower expression
in adult skin. An increase in expression of this gene during fetal but
not adult wound healing suggests a role in controlling mammalian
dermal regeneration and prevention of scar formation [26]. The
LAMC3 (Laminin, gamma-3) gene belongs to the family of
laminins, which are extracellular matrix glycoproteins and the
major noncollagenous constituent of basement membranes. They
have been implicated in a wide variety of biological processes
including intracellular invasion by several bacterial pathogens such
as GAS strains [27]. FIBCD1 (Fibrinogen C domain-containing 1)
is a transmembrane endocytic receptor that binds acetylated
structures via a highly conserved fibrinogen-related domain
(FReD). Ficolins also have FReDs and they play an important
role in innate immunity [28]. FIBCD1 binds chitin and has been
suggested to control the exposure of intestine to chitin and its
fragments, which is important in the immune defense against
parasites and fungi and the modulation of immune response [29].
In addition, fibrinogen is a plasma protein that streptococci adhere
to in order to avoid host defense. ABL1 (c-abl oncogene 1, non-
receptor tyrosine kinase) is a proto-oncogene which encodes
a cytoplasmic and nuclear protein tyrosine kinase implicated in the
processes of cell differentiation, cell division, cell adhesion, and
stress response. ABL tyrosine kinases are related to the cell
penetration of Shigellae and their signaling is required T-cell
development and mature T-cell function [30,31]. Sequencing
revealed no specific genetic variations that would implicate any of
these genes in erysipelas susceptibility.
PTGES (prostaglandin E synthase) is induced by proinflamma-
tory cytokine interleukin 1 beta (IL1B) and synthesizes prosta-
glandin E2 (PGE2), a key regulator of inflammation by modulating
the regulation and activity of T cells and the development and
activity of B cells, and by enhancing the production of cytokines
and antibodies [32]. PGE2 also modulates the severity of infection
caused by GAS [33]. Upon contact with GAS, skin keratinocytes
exert a strong proinflammatory response, resulting in the increased
expression of several cytokines and the rapid release of PGE2 [34].
PTGES is associated with inflammatory diseases, fever, and pain
associated with inflammation, and the deletion of Ptges leads to an
impaired febrile response in mice [35]. We sequenced the introns
and 10kb upstream of the transcription start site of PTGES as well
as the coding region, but found no specific variants, mutations or
indels implicating it directly in erysipelas susceptibility.
Follow-up Genotyping with Higher-density Array
We screened 15 affected patients and 15 unaffected control
individuals with the Affymetrix GeneChip Human Mapping
250KSty Array and focused analysis on the previously identified
regions on chromosomes 3q22 (D3S1306 to D3S1299), 9q34
(D9S290 to D9S1863), 21q22 (D21S1898 to D21S1920), and
22q23 (D22S1159 to D22S1141). The 3q22 locus was the most
significant with several SNPs in the promoter region of the
Angiotensin II type receptor 1 (AGTR1) between SNPs rs9862062
(148359724 bp) and rs4681157 (148412408 bp) showing nominal
association (Table 4).
AGTR1 exons and exon-intron boundaries were sequenced in
six probands from the families showing strongest linkage to the
3q22 region. Twelve known SNPs were identified, including
rs5186 (also known as 1166 A/C) in the 39UTR. The A allele of
Table 2. Finemapping of the 9q34 linkage peak region with
microsatellite markers.
Marker
Physical
locus (bp)
Candidate
genes
Mouse GAS
genesa
130026756–130155828 Garnl3 Q
130882972–130890712 Ptges2 q
D9S918 130457260
130500596–130541048 Sh2d3c q
D9S1827 131001749
D9S290* 131527468
131873228–131911225 Ppp2r4 Q
D9S752* 131951047
D9S972* 132051085
D9S65* 132190620
D9S115* 132248174
D9S1795* 132306492
D9S159* 132369694
D9S1831* 132421728
132427920–132484953 PRRX2
D9S62* 132461670
132500615–132515344 PTGES Ptges q
D9S1861* 133370746
D9S118* 133419164
D9S1863* 133499845
133589268–133763062 ABL1
133777825–133814455 FIBCD1
133884504–133968446 LAMC3
D9S313* 133887414
D9S903* 133935886
D9S64* 134380110
D9S179* 135091628
D9S1847* 135436949
D9S1830* 135715761
D9S1199* 135831155
D9S2157 136035489
139743256–139745490 Phpt1 Q
139756571–139760738 Edf1 Q
139942553–139948505 Entpd2 Q
140069236–140083057 Anapc2 q
The linkage area is marked by asterisks and the highest linkage peaks are
highlighted in bold.
aGenes in the mouse quantitative trait locus for susceptibility to group A
streptococcal (GAS) infections on chromosome 2 [18]. (q) Genes up regulated
and, (Q) down regulated in GAS susceptible mouse strains.
doi:10.1371/journal.pone.0056225.t002
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rs5186 has been associated with increased serum levels of high-
sensitivity C-reactive protein and inflammation, and the CC
genotype is putatively correlated with hypertension [36,37] (Table
S2). Out of six probands, five were homozygous AA, one
heterozygous AC, and none had the CC genotype, thus supporting
a potential role in inflammation for the A allele. However, no
statistically significant difference in allele frequencies was detected
for rs5186 between cases and controls in the acute cohort. No
Figure 2. The NPLall scores from initial non-parametric linkage analysis for the chromosomes showing suggestive linkage. Allele
frequencies for the Affymetrix HMA10K Array were estimated using 20 affected individuals from six families and MERLIN was used for multipoint NPL
analysis.
doi:10.1371/journal.pone.0056225.g002
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other variants that might explain linkage to this region were found
in AGTR1.
We chose two AGTR1 promoter area SNPs (rs9862062 and
rs718424) that showed association to erysipelas in Haploview
analysis, and genotyped them in the family material and in the
acute erysipelas cohort by direct sequencing. The reference G-
allele of rs9862062 was suggestively associated in the combined
family (probands and marry-ins) and acute erysipelas cohort
(Fisher’s exact test, two-tailed p-value 0.006) and the reference T-
allele of rs718424 showed suggestive association with a p-value of
0.017.
Discussion
Individual response to potentially fatal pathogens is modulated
by both environmental and host genetic factors [8,9]. Streptococ-
cal infections can vary from localized pharyngitis or erysipelas to
potentially fatal necrotizing fasciitis and sepsis. We have used
erysipelas/cellulitis, a localized infection of the skin and underlying
subcutaneous tissues to identify 52 families with a possibly
increased susceptibility to streptococcal infections. This is to our
knowledge the largest systematically collected clinical material on
familial segregation of recurrent erysipelas. We performed
a linkage scan on the six most informative families segregating
erysipelas and found evidence for suggestive linkage in seven
chromosomal regions, with a maximum NPL score of 3.84 at
9q34. Further fine mapping of the four most significant regions in
all of the collected families revealed significant linkage to the
chromosome 9q34 region which is syntenic to mouse chromosome
2 (22 to 34 Mb), where a quantitative trait locus (QTL) for GAS
susceptibility in mice has been identified [18]. In mouse, 37
candidate genes involved in immune response, cell signalling,
cellular assembly and organization, and lipid metabolism were
studied for quantitative expression levels pre- and postinfection in
strains resistant and susceptible to severe GAS infection. Genes
associated with early immune response and upregulated in
susceptible strains and downregulated in resistant strains included
Il1a, Il1rn (both located on 2q14 in humans), Ptges (located on 9q34
the linkage peak identified here), and Ptges2 (located proximal to
the 9q34 linkage peak) (Table 2). Increased production of
prostaglandins has also been associated with Gram positive
infections including Streptococcus suis, group B streptococcal, and
GAS skin infections [34,38–40]. However, sequencing of PTGES
and four other chosen candidate genes in the 9q34 linkage region
did not reveal significant genetic variations implicating any of
these genes in erysipelas susceptibility. However, it is possible that
quantitative expression level analysis of candidate genes could
have revealed variation associated with erysipelas [18]. Expression
analysis for the candidate genes was not performed in this study.
The genes for sequencing were chosen based on their known
function and thus, we could have missed genes with yet unknown
roles in immunity and infection. The inherent property of genetic
linkage is the relatively broad genomic area that is implicated. In
this case, the 9q34 region contained 59 genes that in this study
were impractical to sequence. Our rationale for choosing target
genes was then necessarily based on known functional information
and biological plausibility, and we admit this approach has its
limitations. More candidate genes will need to be considered as
data accumulate. Susceptibility to infection is a complex trait
where multiple genes in an immunological pathway or multiple
intertwining pathways play a role in disease outcome [18].
Higher density analysis with the Affymetrix HMA250K Array
revealed the nominal association to erysipelas of several SNPs in
the promoter region of AGTR1 on 3q22. AGTR1 is a G-protein-
coupled receptor that mediates the major cardiovascular effects of
angiotensin II, a potent vasopressor hormone involved in the
development of hypertension, atherosclerosis, and insulin re-
sistance. Angiotensin II is the end product of the renin-angiotensin
system (RAS), where renin stimulates the production of angioten-
sin I from angiotensinogen, which is then converted to angiotensin
II by angiotensin converting enzyme (ACE). The activation of the
RAS correlates with organ injury and mortality in clinical sepsis,
possibly by contributing to the enhanced microvascular tone [41].
Angiotensin II also exerts proinflammatory effects on leukocytes,
endothelial cells, and vascular smooth muscle cells and by acting
through AGTR1, it increases the expression of cytokines,
chemokines, growth factors, and adhesion molecules [42].
Polymorphisms in both ACE and other angiotensinogen genes
have been associated with susceptibility to inflammatory diseases
such as SLE and psoriasis with frequent tonsillitis [43,44]. The
Angiotensin II pathway also plays a potential role in septic shock
[45]. Selected SNPs in ACE, AGTR1, and Angiotensin receptor
associated protein (AGTRAP) showed significant association with
increased 28-day mortality to septic shock for the GG genotype of
AGTRAP rs11121816. AGTRAP interacts specifically with the C-
terminal tail of AGTR1, and negatively regulates the receptor
leading to a functional desensitization to angiotensin II. Pharma-
cological blockage of the RAS is used to treat hypertension,
diabetic nephropathy, and congestive heart failure, but antigen II
receptor blockers (ARBs) and ACE inhibitors also suppress
proinflammatory cytokines and reduce oxidative stress. Prior
usage of ARBs has been shown to reduce mortality in patients
hospitalized for sepsis [46].
Table 3. Non-parametric genome-wide linkage analysis results with MERLIN.
Chromosomal locus Max NPLall Genome-wide p-value Marker(s) Physical locus (bp)
3q22 3.25 0.64 rs361239-rs1429759 136701295–137656598
3p24 2.53 0.97 rs1994987 30456489
3p22 2.64 0.94 rs2167176 35383108
9q34 3.84 0.24 rs578802-rs708616 135453277–135564946
10q25 2.40 0.98 rs1337987-rs959127 113538188–113611569
11q24 2.27 1.00 rs1940007-rs1940006 126754451–126754515
21q22 3.24 0.64 rs743337-rs717205 35265524–35310905
22q13 2.83 0.83 rs719925-rs136578 45758758–45770619
Max NPLall =maximum non-parametric linkage score when testing for allele sharing among affected individuals.
doi:10.1371/journal.pone.0056225.t003
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Polymorphisms in AGTR1 and especially the C allele of rs5186
(+1166A.C) have been associated with hypertension and the A
allele of rs5186 has been associated with higher serum levels of
high-sensitivity C-reactive protein (CRP) and inflammation
[36,37]. Out of our six probands five were homozygous AA, one
heterozygous AC, and none had the CC genotype. In the presence
of AA or AC genotypes microRNA-155 (miR-155) represses
expression of the AGTR1 protein [47]. MiR-155 mediated
translational repression can be regulated by, e.g., TGFB1, and
MiR-155 expression is significantly increased with the AA or AC
genotypes as compared to the CC genotype. MiR-155 is critically
involved in the control of specific differentiation processes in the
immune response. It functions specifically in regulating T helper
cell differentiation and the germinal center reaction to produce an
optimal T cell–dependent antibody response, mediated at least
partly by regulating cytokine production [48]. Furthermore, the
loss of MiR-155 leads to an overall attenuation of immune
responses in mouse [49]. High CRP levels and leukocyte counts
(i.e., a more severe inflammatory response) in erysipelas are
associated with recurrence of erysipelas [5]. Our finding of
predominance of the A-allele in our six probands is consistent with
these earlier observations. Interestingly, AGTR1 and PTGES are
involved in the same pathway, as AGTR1 induces the production
of COX, which coverts arachidonic acid into Prostaglandin H2
that in turn is converted by PTGES into Prostaglandin E2.
We found evidence for host genetic factors influencing
susceptibility to bacterial non-necrotizing erysipelas/cellulitis, but
did not find a common susceptibility factor in all families. We did
not find linkage or association with the HLA region previously
linked with GAS infection severity in humans [19,20]. It is likely
Table 4. Affymetrix HMA250K results for 3q22.
SNP
Physical
locus (bp) Gene; position Haploview Haploview
Shared
heterozygosity
Haplotype
pattern mining
Haplotype pattern
mining
Associated allele p-value p-value Score
rs2091023 148265311 G 0.787 0.460 16
rs12490567 148274505 G 0.775 0.336 32
rs1522940 148315687 G 0.389 0.169 59
rs2687661 148319233 T 0.795 0.046 101
rs6803324 148335030 A 0.313 x 0.013 142
rs6440561 148358582 C 0.044 x 0.012 194
rs6440562 148358705 x 0.010 218
rs9862062* 148359724 G 0.045 x 0.013 259
rs9811115* 148360046 A 0.045 x 0.023 263
rs275679 148368303 G 0.129 x 0.040 231
rs10513336 148368387 x 0.078 188
rs275711 148374631 T 0.230 x 0.084 163
rs718424 148380543 C 0.045 x 0.082 164
rs2087737 148381522 T 0.045 x 0.092 140
rs16860674 148382002 x 0.108 90
rs872212 148386747 T 0.166 x 0.108 55
rs2012052 148386856 A 0.166 x 0.113 36
rs454530 148400657 C 0.228 x 0.113 25
rs2638359 148406383 T 0.228 x 0.086 19
rs2638358 148406537 A 0.228 x 0.119 18
rs2638357 148406619 A 0.228 x 0.119 22
rs2933251 148406799 T 0.228 x 0.096 39
rs409742 148412365 C 0.228 x 0.091 59
rs4681157 148412408 T 0.045 x 0.080 80
rs12721267 148416327 AGTR1; intron 1 x 0.082 76
rs12695877 148427034 AGTR1; intron 2 0.105 74
rs1492103 148432964 AGTR1; intron 2 G 0.129 0.113 68
rs12695918 148456627 AGTR1; intron3 0.123 58
rs13097326 148468746 C 0.197 0.126 50
The haplotype that was significantly associated to erysipelas in Haploview is marked with bold letters in the ‘‘Associated allele’’ column. Significant p-values in
Haploview or Haplotype pattern mining (HPM) for individual SNPs are also highlighted in bold. SNPs belonging to the associated haplotype and a significant p-value in
Haploview, and with a significant p-value in HPM, and that showed shared heterozygosity among cases are marked with an asterisk.
doi:10.1371/journal.pone.0056225.t004
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that as the inflammatory pathways are very complex and the
defense against infections is under strong selection, different
families are likely to have individual genetic susceptibilities.
Genetic heterogeneity makes it difficult to find significant
correlations, which is a common pitfall of studies on host genetic
factors predisposing to infections. Much larger patient and control
groups will be needed to verify these preliminary results. However,
our linkage peak and the region of strongest association coincide
with genes and pathways suggested to play important roles in
susceptibility to streptococcal infections. The identification of the
susceptibility genes would help to understand better the course of
infections and ultimately reduce morbidity.
Supporting Information
Figure S1 NPL plots for the fine mapping of the
chromosome 9q34 linkage peak with 22 microsatellite
markers. The NPL plots for the four configurations were
essentially identical. MERLIN was used for multipoint NPL
analyses using four configurations. (A) In configuration 0,
unconfirmed affected individuals were analyzed as unknown,
and (B) in configuration 2, they were analyzed as affected. In
configurations (C) 0_186 and (D) 2_186, analysis was identical to
configurations 0 and 2, respectively, except that allele 186 was
called for marker D9S65.
(TIF)
Table S1 Family-wise NPLall scores for the 9q34 linkage
region. Families showing significant linkage are shaded dark grey.
Families showing suggestive linkage are shaded light grey.
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Table S2 SNPs found in the family probands in AGTR1.
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